CVE-2026-123051
Low 1.2No known exploitationFix status unknownTitle not yet published
Record last updated
CVSS score
1.2
Low on a 0 to 10 scale
EPSS, chance of exploitation in 30 days
0.2%
Higher than 8% of scored CVEs. A prediction, not evidence.
CISA remediation deadline
None
Not in the KEV catalog
Description
The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for integration with the IZS platform. An attacker with access to the executable could extract and reuse the credentials, potentially leading to unauthorized access to integration resources or manipulation of associated information, depending on the privileges granted and authentication controls in place.
Weakness: CWE-798
Patching and mitigation
- Patch status
- Unknown: no source documents a fix
- Mitigation
- None documented
- Vendor guidance
- No vendor link on record
Affected products
No affected products documented yet.
Timeline
- No dated events documented yet.